https://ei-lca.com/wp-content/uploads/2026/03/immunity-versus-new-therapy-1.pdf

ei-lca.com/wp-content/u...
“Immunity versus new therapy”. A battle for greater influence inside the human eye, and when fiction could become reality. March 24, 2026.
@social.npo.one @fightblindness.bsky.social lindness.bsky.social @sarepta.com
#LCA10 #blindness

CNBC Cures 2026 Bringing together influential investors, policy makers and leaders in biotechnology to accelerate the future of medicine through breakthroughs in rare disease research.

www.cnbcevents.com/cures/
" It is a call to action: to reimagine healthcare, unlock bold new solutions, and accelerate a future where scientific breakthroughs for the rare disease community"
#LCA10 #blindness @cnbc.com @fightblindness.bsky.social
@retinauk.bsky.social @retinaint.bsky.social

@dubaieye.bsky.social #LCA10 #blindness #RNA #WRDD2026

@fnr.lu @middleeasteye-rss.bsky.social @iowalionseyebank.bsky.social @eye-tuebingen.bsky.social @newseye.bsky.social
Find more and read on (www.ei-lca.com)

Nordic Rare Disease Summit 2025 Act 2030: Pushing Boundaries for Rare - 16 & 17 September, Copenhagen

September 16 & 17, 2025; Copenhagen, Denmark
nordicrarediseasesummit.org#ABODesire
Nordic Rare Disease Summit 2025
Act 2030: Pushing Boundaries for Rare

#RareDisease #lca10

National Convention Virtual Experience | National Federation of the Blind Unable to attend convention in-person? Register for the virtual experience. Stream convention general sessions, access the app, and get a chance to win door prizes.

Register for the virtual experience. Stream convention general sessions, access the app, and get a chance to win door prizes.

July 8 through 13, 2025, plus pre-convention activities!
nfb.org/get-involved...
@fightblindness.bsky.social @riccobono.bsky.social #LCA10 #RareDisease #blindness

LA Community Connections - June Presentation Presentation by Dr. Jacque Duncan from UCSF

Wednesday, June 25th, 2025, 7:00 p.m. – 8:30 p.m. (PDT)
Presentation by Dr. Jacque Duncan from UCSF
www.fightingblindness.org/events/la-co...
@fightblindness.bsky.social @rnc.ac.uk #lca10 #RareDisease

Oligonucleotide Conferences 2026 | mRNA Therapeutics Conferences 2026| RNA Therapeutics Conference 2026| Oligonucleotide Events 2026 | Oligonucleotide Meetings 2026 | World Conference on Oligonucleoti... Oligonucleotide Conferences 2026 , mRNA Therapeutics Conferences 2026, RNA Therapeutics Conference 2025, Oligonucleotide Events 2026 , Oligonucleotide Meetings 2026, World Conference on Oligonucleotid...

@otdc-2026.bsky.social Oligonucleotide Therapeutics and Delivery Conference is all set to happen on March 23-24, 2026 as a hybrid event in Rome, Italy
oligo-nucleotide.com
#RareDisease #LCA10 #Blindness #oligonucleotide

RARE Advocacy Exchange Global Genes’ RARE Advocacy Exchange is a virtual event designed to empower, equip, and elevate individuals with the leadership skills to help make a change through a series of 8 sessions. We’re creat...

globalgenes.org/rare-advocac...
Global Genes’ RARE Advocacy Exchange is a virtual event designed to empower, equip, and elevate individuals with the leadership skills to help make a change through a series of 8 sessions.
@globalgenes.bsky.social #blindness #LCA10 #RareDisease

#LCA10 #blindness #raredisease #orphandrugs

Home Page - Retina Australia This is an example page. It's different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduc...

www.retinaaustralia.com.au
Retina Australia funds and facilitates the top medical research into inherited retinal diseases (IRDs) through a competitive annual Research Grants Program.
#LCA10 #RareDisease #OrphanDrugs

Eye2Gene Eye2Gene is a research project. The aim is to engineer artificial intelligence that can look through photographs and scans of retinas, and accurately predict which inherited retinal disease may ...

Artificial intelligence (AI) is a computer program built to perform a specific task. It gets better at that task the more it does it. This ability to learn can solve problems in medical research.
eye2gene.com
#raredisease #lca10 #retina
@ucldiscovery.bsky.social

ClinicalTrials.gov

Study to Evaluate Sepofarsen in Subjects with Leber Congenital Amaurosis (LCA) Type 10 (HYPERION) (HYPERION)
clinical trial ID: NCT06891443
Sponsor- Laboratoires Thea. #blindness #LCA10 #CEP290
clinicaltrials.gov/study/NCT068...

KENWOOD LCA-10
なかなか良き😌
#kenwood
#lca10
#オーディオ